MedTrace Logo

Observational MyPal-Child Study on the ePRO-based Early Palliative Care Digital System in Paediatric Oncology Patients

NCT04381221 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-03-29

No results posted yet for this study

Summary

The main aim of the study is the evaluation of the feasibility of comprehensive service which has been developed while considering patient-orientated needs. With regard to the study, apps have been developed for both groups of participants, parents and their child which suffers from cancer. These apps aim at supporting the documentation and communication of the own condition. This includes for example a video game which can be played via tablet or smartphone in which questions appear addressing the personally perceived burden by children amongst other things. Participants of the study are children between 6 and 17 years of age which suffer from leukemia or tumors. Further participants of the study are at least one of the patient's parents. It is an observational study. Within the course of the study, the usual treatment is not altered actively by the study, it is, however, supplemented by questionnaires which will be analyzed being anonymized after the end of the study running time.

Conditions

  • Leukemia, Childhood
  • Solid Tumor, Childhood

Sponsors & Collaborators

  • Universität des Saarlandes

    collaborator OTHER

  • Brno University Hospital

    collaborator OTHER

  • Hannover Medical School

    collaborator OTHER

  • Centre for Research and Technology Hellas

    lead OTHER

Principal Investigators

  • Kostas Stamatopoulos, MD · Representative of the Sponsor: Centre for Research & Technology Hellas

  • Annette Sander, MD · Medical School Hannover

  • Petr Lokaj, MD · University Hospital Brno

  • Norbert Graf, Professor MD · Universität des Saarlandes

  • Norbert Grad, Professor MD · Universität des Saarlandes

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-22
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Czechia
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04381221 on ClinicalTrials.gov